126 related articles for article (PubMed ID: 33144282)
1. Drug Use and Cancer Risk: A Drug-Wide Association Study (DWAS) in Norway.
Støer NC; Botteri E; Thoresen GH; Karlstad Ø; Weiderpass E; Friis S; Pottegård A; Andreassen BK
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):682-689. PubMed ID: 33144282
[TBL] [Abstract][Full Text] [Related]
2. Drug-Wide Association Study (DWAS): Challenges and Opportunities.
Wang Y; Gadalla SM
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):597-599. PubMed ID: 33811172
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study.
Andreassen BK; Støer NC; Martinsen JI; Ursin G; Weiderpass E; Thoresen GH; Debernard KB; Karlstad Ø; Pottegard A; Friis S
BMJ Open; 2019 Apr; 9(4):e028504. PubMed ID: 30962244
[TBL] [Abstract][Full Text] [Related]
4. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
5. Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study.
Romanowska J; Bjornevik K; Cortese M; Tuominen JA; Solheim M; Abolpour Mofrad A; Igland J; Scherzer CR; Riise T
Neurology; 2023 Nov; 101(21):e2068-e2077. PubMed ID: 37816645
[TBL] [Abstract][Full Text] [Related]
6. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
7. Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study.
Berge LAM; Andreassen BK; Stenehjem JS; Heir T; Karlstad Ø; Juzeniene A; Ghiasvand R; Larsen IK; Green AC; Veierød MB; Robsahm TE
Clin Epidemiol; 2020; 12():1389-1401. PubMed ID: 33376408
[TBL] [Abstract][Full Text] [Related]
8. Hormonal and reproductive influences and risk of melanoma in women.
Smith MA; Fine JA; Barnhill RL; Berwick M
Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient Registry.
Benjaminsen E; Myhr KM; Grytten N; Alstadhaug KB
Mult Scler Relat Disord; 2021 Feb; 48():102691. PubMed ID: 33360174
[TBL] [Abstract][Full Text] [Related]
10. Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women.
Kvåle G; Heuch I; Nilssen S
Int J Epidemiol; 1994 Aug; 23(4):691-9. PubMed ID: 8002181
[TBL] [Abstract][Full Text] [Related]
11. Systematic assessment of prescribed medications and short-term risk of myocardial infarction - a pharmacopeia-wide association study from Norway and Sweden.
Sen A; Vardaxis I; Lindqvist BH; Brumpton BM; Strand LB; Bakken IJ; Vatten LJ; Romundstad PR; Ljung R; Mukamal KJ; Janszky I
Sci Rep; 2019 Jun; 9(1):8257. PubMed ID: 31164670
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study.
Hálfdánarson ÓÖ; Fall K; Ogmundsdottir MH; Lund SH; Steingrímsson E; Ogmundsdottir HM; Zoega H
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):471-478. PubMed ID: 30565786
[TBL] [Abstract][Full Text] [Related]
13. Risk of infertility in female adolescents and young adults with cancer: a population-based cohort study.
Velez MP; Richardson H; Baxter NN; McClintock C; Greenblatt E; Barr R; Green M
Hum Reprod; 2021 Jun; 36(7):1981-1988. PubMed ID: 33611573
[TBL] [Abstract][Full Text] [Related]
14. Recall bias in melanoma risk factors and measurement error effects: a nested case-control study within the Norwegian Women and Cancer Study.
Parr CL; Hjartåker A; Laake P; Lund E; Veierød MB
Am J Epidemiol; 2009 Feb; 169(3):257-66. PubMed ID: 19011116
[TBL] [Abstract][Full Text] [Related]
15. Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened.
Friedman GD; Udaltsova N; Chan J; Quesenberry CP; Habel LA
Cancer Causes Control; 2009 Dec; 20(10):1821-35. PubMed ID: 19582585
[TBL] [Abstract][Full Text] [Related]
16. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors and fracture risk. The HUNT study, Norway.
Hoff M; Skovlund E; Skurtveit S; Meyer HE; Langhammer A; Søgaard AJ; Syversen U; Forsmo S; Abrahamsen B; Schei B
Osteoporos Int; 2020 Jan; 31(1):109-118. PubMed ID: 31741023
[TBL] [Abstract][Full Text] [Related]
18. Reproductive factors and risk of melanoma: a population-based cohort study.
Støer NC; Botteri E; Ghiasvand R; Busund M; Vangen S; Lund E; Veierød MB; Weiderpass E
Br J Dermatol; 2019 Aug; 181(2):282-289. PubMed ID: 30748007
[TBL] [Abstract][Full Text] [Related]
19. Cross-sectional survey of off-label and unlicensed prescribing for inpatients at a paediatric teaching hospital in Western Australia.
Landwehr C; Richardson J; Bint L; Parsons R; Sunderland B; Czarniak P
PLoS One; 2019; 14(1):e0210237. PubMed ID: 30620749
[TBL] [Abstract][Full Text] [Related]
20. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
